At MH Combiotic Inc., I assessed more than 40 technical files for an antimicrobial wound hydrogel against 21 CFR Part 820 and FDA eSTAR expectations. I applied root cause analysis to identified quality gaps and authored predicate device comparisons to support 510(k) submission readiness.
At Biogen, I maintained audit-ready records for more than 100 regulated items and developed a Hazmat Indication framework that reduced classification errors by 30%. At Cairn Diagnostics, I prepared and updated technical dossiers, including EU MDR Technical Files and Clinical Evaluation Reports, supporting CE mark maintenance.

